期刊文献+

血液透析长期中心静脉导管留置功能不良的影响因素分析 被引量:5

Factors influencing dysfunction of long-term indwelling central venous catheters for hemodialysis
下载PDF
导出
摘要 目的探讨长期中心静脉导管功能不良的影响因素。方法以长期中心静脉导管为血管通路的维持性血液透析患者158例为研究对象,根据是否发生导管功能不良分为功能良好组112例和功能不良组46例。比较两组血红蛋白(Hb)、血细胞比容(Hct)、白蛋白(Alb)、血小板(Plt)、血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、超敏C反应蛋白(hsCRP)、凝血酶原时间(PT)、部分活化的凝血酶时间(APTT)、血流量(BF)、纤维蛋白原(FIB)、超滤量(UF)、尿素清除指数(Kt/v)、导管留置时间、导管相关感染、封管方法、是否患有糖尿病、口服抗凝药物情况。利用logistic回归分析导管功能不良的影响因素。结果功能良好组较功能不良组Alb(38.7±5.6)g/L vs(36.6±5.4)g/L和BF(256.41±25.8)ml/min vs(218.26±26.6)ml/min较高,hsCRP(3.24±2.11)mg/L vs(6.38±4.18)mg/L较低(P<0.05或<0.01),导管相关感染发生率较低,23.2%(26/112)vs 45.7%(21/46);尿激酶封管率较高31.3%(35/112)vs 13.0%(6/46)(P<0.05或<0.01);Logistic回归结果显示:较高的hsCRP,导管相关感染是导管功能不良发生的危险因素。而较高的血清Alb和每周1次尿激酶替代肝素封管是降低导管功能不良的影响因素。结论提高患者的Alb水平,控制导管相关感染的发生,降低hsCRP水平,每周1次尿激酶代替肝素封管有利于降低中心静脉导管功能不良的发生。 Objective To explore the factors influencing the dysfunction of long-term indwelling central venous catheters for hemodialysis. Methods We analyzed 158 maintenance hemodialysis patients who used long-term indwelling cuffed catheter. Patients were assigned into function and dysfunction group according to the function of their catheters,function group 112 and dysfunction group 46. Their hemoglobin ( Hb), hematoerit (Hct), serum albumin ( Alb), plateiet ( PLT), total cholesterol ( TC), triglyceride ( TG), low density lipoprotein cholesterol ( LDL-C), high sensitivity C-reactive protein( hsCRP), prothrombin time ( PT), activated partial thromboplastin time ( APTT), blood flow(BF), fibrinogen(FIB), Ultrafiltration volume(UF), Kt/v, time of catheter dialysis, catheter related infections, catheter locking methods,diabetes or not, and oral anticoagulants drug therapy were measured or recorded to compare the differences between two groups. Independent predictors of catheter dysfunction were determined by multivariate logistic regression. Results The function group had higher Alb, blood flow and lower hsCRP in comparison with the dysfunction group,Alb(38. 7±5. 6) g/L vs (36.6±_5.4)g/L,BF(256.41±25.8) ml/min vs (218.26±26.6) ml/min, hsCRP(3.24±2.11) mg/L vs (6.38±4.18) mg/L( P 〈0.05 or〈0.01). The function group had lower rate of catheter related infection than the dysfunction group, 23.2% ( 26/112 ) vs 45.7% ( 21/46 ) ; higher percentages of urokinase instead of heparin locking solution,31.3%(35/112)vs 13.0%(6/46)( P 〈0.05 or 〈0.01). By multivariate logistic regression, higher hsCRP and catheter related infection were the risking factors of catheter dysfunction, higher Alb and rokinase instead of heparin once weekly as a locking solution were the influencing factors of lower catheter dysfunction. Conclusion Enhancing AIB, controlling catheter related infection, redueing hsCRP, rokinase instead of heparin once weekly as a locking solution may lower the dysfunction rate of central venous catheters.
出处 《临床荟萃》 CAS 2013年第11期1216-1219,共4页 Clinical Focus
关键词 肾疾病 肾透析 导管插入术 中心静脉 kidney disease renal dialysis catheterization, cental venous catheter
  • 相关文献

参考文献15

  • 1NKF-KDOQI Vascular Access Work Group. Clinical practice guidelines for vascular access [J]. Am J Kidney Dis, 2006,48 (Suppl 1) :S248-S273.
  • 2Rayner HC, Pisoni RL. The increasing use of hemodialysis catheters: evidence from the DOPPS on its significance and ways to reverseit[J]. Semin Dial, 2010,23 ( 1 ) : 6-10.
  • 3Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study[J]. J Am Soc Nephrol, 2002,13 (8) :2133-2139.
  • 4李京,戴晓霞,张宜默,左力,金其庄.血液透析长期中心静脉留置导管功能不良发生率及影响因素分析[J].中国血液净化,2010,9(4):178-181. 被引量:39
  • 5Mandolfo S,Piazza W,Galli F. Central venous catheter and the hemodialysis patient: a difficult symbiosis [J]. J Vasc Access, 2002,3(2) :64-73.
  • 6Mehall JR, Saltzman DA, Jackson RJ, et al. Fibrin sheath enhances central venous catheter infectionrJ-. Crit Care Med, 2002,30(4): 908-912.
  • 7Chan MR. Hemodialysis central venous catheter dysfunction [J]. Semin Dial,2008,21(6) :516-521.
  • 8Suojanen JN, Brophy DP, Nasser I. Thrombus on indwelling central venous catheters: the histopathology of " Fibrin sheaths"[J]. Cardiovasc Intervent Radiol, 2000, 23 ( 3 ) : 194-197.
  • 9Chou CY,Kuo H L, Yung YF, et al. C-reactive protein predicts vascular access thrombosis in hemodialysis patients[J]. Blood Purif, 2006,24 (4) : 342-346.
  • 10Chen TC, Wang IK, Lee CH, et al. Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: aretrospective study[J]. Int J Clin Pract, 2006,60(12): 1596-1599.

二级参考文献11

  • 1Tanriover B, Carlton D, Saddekni S, et al. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies[J]. Kidney Int, 2000,57: 2151-2155.
  • 2Ⅲ NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000[J]. Am J Kidney Dis, 2001,37:8137- 181.
  • 3Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomized controlled study[J]. J Am Soc Nephrol, 2002, 13:2133 2139.
  • 4Wilkin TD, Kraus MA, Lane KA, et al. Internal jugular vein thrombosis associated with hemodialysis catheters[J]. Radiology, 2003,228:697-700.
  • 5Schwab SJ, Beathard G. The hemodialysis catheter conundrum: Hate living with them, hut can't live without them[J]. Kidney Int, 1999,56:1-17.
  • 6Suhocki PV, Conlon PJ Jr, Knelson MH, et al. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction[J]. Am J Kidney Dis, 1996,28:379-386.
  • 7Alomari AI, Falk A. The natural history of tunneled hemodialysis catheters removed or exchanged: a singleinstitution experience[J]. J Vase Interv Radiol, 2007, 18:227-235.
  • 8Osmic I, Resic H, Barhawi H, et al. Central venous catheters for haemodiaiysis and optimal blood flow[J]. Med Arh, 2006,60:237-239.
  • 9Junor BT. Hematocrit above 30% in continuous ambulatory peritoneal dialysis patients treated with erythropoietin is harmful[J]. Perit Dial Int, 1993,13 Suppl 2:S535-537.
  • 10Shinaherger JH, Miller JH, Gardner PW. Erythropoietin alert: risks of high hematocrit hemodialysis[J]. ASAIO Trans, 1988,34:179-184.

共引文献38

同被引文献45

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部